Merck buys Schering-Plough for $41bn
The US pharmaceutical group unveiled an agreed $41bn takeover of Schering-Plough, in a deal which will substantially strengthen Merck’s products pipeline at a time of growing pressure on existing products
March 9, 2009
No Comments
No comments yet.
RSS feed for comments on this post. TrackBack URL
Sorry, the comment form is closed at this time.